Clinical trial
Non-interventional Study to Observe Triple Combination Therapy With Boceprevir or Simeprevir Plus Peginterferon Alfa-2a Plus Ribavirin for Re-treatment of Chronic Hepatitis C in Hungary (IMPERIAL)
NCT02118597 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Non-interventional Study to Observe Triple Combination Therapy With Boceprevir or Simeprevir Plus Peginterferon Alfa-2a Plus Ribavirin for Re-treatment of Chronic Hepatitis C in Hungary (IMPERIAL)
- Lead sponsor
- Hoffmann-La Roche
- Phase
- Observational
- Overall status
- Terminated
- Start date
- May 31, 2014
- Completion date
- May 31, 2015
- Enrollment
- 19 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.